AFP and gastric adenocarcinoma: Successive investigations revealed that irrespective of pathological morphology, instances of positive AFP immunohistochemistry or increased sAFP had a suggestive risk of progression, which was termed “AFP-producing gastric adenocarcinoma (40)”.